Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death
Xuhui Bao, Liyi Xie
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Therapeutic targeting of tumour myeloid cells
Simon T. Barry, Dmitry I. Gabrilovich, Owen J. Sansom, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 216-237
Closed Access | Times Cited: 152
CD39/CD73/A2AR pathway and cancer immunotherapy
Chenglai Xia, Shuanghong Yin, Kenneth K.W. To, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 143
Tantalum–Zirconium Co‐Doped Metal–Organic Frameworks Sequentially Sensitize Radio–Radiodynamic–Immunotherapy for Metastatic Osteosarcoma
Tao Li, Mingquan Gao, Zifei Wu, et al.
Advanced Science (2023) Vol. 10, Iss. 10
Open Access | Times Cited: 46
Radiation‐Induced Immunogenic Cell Death for Cancer Radioimmunotherapy
Teng Liu, Pei Pei, Wenhao Shen, et al.
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 46
Mitochondria‐Targeted Nanoadjuvants Induced Multi‐Functional Immune‐Microenvironment Remodeling to Sensitize Tumor Radio‐Immunotherapy
Zaigang Zhou, Cheng Li, Chao Li, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Open Access | Times Cited: 17
Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
Shuyan He, Lu Zheng, Chunjian Qi
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Amplifying “eat me signal” by immunogenic cell death for potentiating cancer immunotherapy
Yong Xi, Lijie Chen, Jian Tang, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 94-114
Closed Access | Times Cited: 40
Identification of Key Biomarkers Associated with Immunogenic Cell Death and Their Regulatory Mechanisms in Severe Acute Pancreatitis Based on WGCNA and Machine Learning
Zhengjian Wang, Jin Liu, Yuting Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3033-3033
Open Access | Times Cited: 36
CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks
Lusine Hovhannisyan, Carsten Riether, Daniel M. Aebersold, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 35
The Clinical Significance of CD73 in Cancer
Niklas Bach, Riekje Winzer, Eva Tolosa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11759-11759
Open Access | Times Cited: 30
Radiotherapy-activated tumor immune microenvironment: Realizing radiotherapy-immunity combination therapy strategies
Haifen Luo, Wen Ma, Qi Chen, et al.
Nano Today (2023) Vol. 53, pp. 102042-102042
Closed Access | Times Cited: 23
Pyroptotic cell death: an emerging therapeutic opportunity for radiotherapy
Hongbin Li, Tiantian Yang, Jialin Zhang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 10
Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot
Yiman Han, Xin Tian, Jiaqi Zhai, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 9
Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors
Yuze Wu, Ming Yi, Mengke Niu, et al.
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 739-760
Open Access | Times Cited: 8
Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds
Mina Amiri, Ommoleila Molavi, Shahnaz Sabetkam, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 21
Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system
Kenny Misael Calvillo‐Rodríguez, Helen Yarimet Lorenzo-Anota, Cristina Rodríguez‐Padilla, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Metabolic crosstalk: Extracellular ATP and the tumor microenvironment in cancer progression and therapy
Sourav Shukla, Parameswar Dalai, Reena Agrawal-Rajput
Cellular Signalling (2024) Vol. 121, pp. 111281-111281
Closed Access | Times Cited: 6
Low-intensity focused ultrasound targeted microbubble destruction reduces tumor blood supply and sensitizes anti-PD-L1 immunotherapy
Nianhong Wu, Yuting Cao, Ying Liu, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 16
Low-Dose Non-Targeted Effects and Mitochondrial Control
D. Averbeck
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11460-11460
Open Access | Times Cited: 16
Lenvatinib resistance mechanism and potential ways to conquer
Wentao Bo, Yan Chen
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models
Jian Ye, Nicholas W Gavras, David C Keeley, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 5, pp. e006842-e006842
Open Access | Times Cited: 13
Combining spatially fractionated radiation therapy (SFRT) and immunotherapy opens new rays of hope for enhancing therapeutic ratio
Qiuxia Lu, Weisi Yan, Alan Zhu, et al.
Clinical and Translational Radiation Oncology (2023) Vol. 44, pp. 100691-100691
Open Access | Times Cited: 13
Carrier-adjuvanted immunostimulator to boost photodynamic immunotherapy by downregulating PD-L1 and impairing ATP hydrolysis
Yi Cen, Ying Chen, Hua Cai, et al.
Science China Materials (2025)
Closed Access
polydopamine-based nanoadjuvants promote a positive feedback loop for cancer immunotherapy via overcoming photothermally boosted T cell exhaustion
Xiao-Kai Chi, Hairui Zhang, Jingjing Gao, et al.
Biomaterials Research (2025) Vol. 29
Open Access
Cutting‐Edge Therapy and Immune Escape Mechanisms in EBV‐Associated Tumors
Jie Wang, Rong Wang, Meifeng Wang, et al.
Medicinal Research Reviews (2025)
Closed Access
Page 1 - Next Page

Scroll to top